Emtricitabin i kombination med andre antiretrovirale midler, herunder nukleosidanaloger, non- nukleosidanaloger og proteasehæmmere har vist sig at være effektive ved behandlingen af HIV- infektion hos behandlingsnaive patienter og behandlingserfarne patienter med stabil, virologisk kontrol.
Emtricitabine in combination with other antiretroviral agents, including nucleoside analogues, non-nucleoside analogues and protease inhibitors, has been shown to be effective in the treatment of HIV infection in treatment-naïve patients and treatment-experienced patients with stable virological control.